Because of the close similarity between the microscopic appearance of the focal granulomas seen in Crohn's disease and those of sarcoidosis, patients with Crohn's disease were included in a study of the specificity of the Kveim test. This paper summarizes the preliminary findings.
Patients
The aim was to make Kveim tests in patients with active or recently active Crohn's disease who had not previously had steroids and who were unlikely to receive treatment with steroids during the period (4) (5) (6) (1969, ii, 571-573) and is reproduced by kind permission of the Editor. 
Discussion
The Kveim test material used in the present study was derived from a single lot of a spleen which has been established as potent for sarcoidosis in a double-blind evaluation (Mitchell, Sutherland & Bradstreet, 1969 (Siltzbach, personal communication; Mitchell, 1968a (Kooij & Gerritsen, 1958; Kooij, 1963; Pearson et al., 1969) and also in apparently healthy subjects who showed no evidence of sarcoidosis or other disease, and who failed to show conversion to tuberculin sensitivity following two technically satisfactory BCG vaccina-tions (Hart, Mitchell & Sutherland, 1964; Mitchell et al., 1967 Mitchell et al., , 1968b .
